<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Non-Hodgkin Lymphoma

Research    Blood Cancer    Non-Hodgkin Lymphoma

Phase III clinical trial results support rituximab as new standard-of-care in pediatric Burkitt lymphoma

Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated with the addition of anti-cancer immunotherapy rituximab to standard chemotherapy. The trial represents a major international collaboration between the European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the Children’s Oncology Group (COG), and was led in the United States by Thomas Gross, MD, PhD, University of Colorado Cancer Center investigator and pediatric oncologist at Children’s Hospital Colorado, and in Europe by Véronique Minard-Colin, MD and Catherine Patte, MD, both pediatric oncologists at the Gustave Roussy Department of Child and Adolescent Oncology in Paris, France. The addition of rituximab decreased treatment failures by 70 percent resulting in a 10 percent increase in the three-year survival rate seen with chemotherapy alone (LMB protocol).


Author Cancer Center | Publish Date June 03, 2020
Full Story

CU Cancer Center In the News

The Denver Post

Wings of Hope Raises More than $100,000 for Pancreatic Cancer Research at CU Cancer Center

news outletThe Denver Post
Publish DateOctober 05, 2021

Despite the continuing effects of COVID-19, a dedicated community of supporters converged Sept. 18 for the sold-out Evening of Hope, generating more than $100,000 to benefit pancreatic cancer research at the University of Colorado Cancer Center.

Full Story
Denver 7

Robotic Technology Takes Us into a New Era of Drug Discovery

news outletDenver 7
Publish DateSeptember 30, 2021

A giant robot at CU Anschutz Medical Campus is busy doing lifesaving work. Dan LaBarbera is the founding director at the Center for Drug Discovery at the campus.

Full Story
Healio

Animal imaging researcher wins award for contribution to oncology research

news outletHealio
Publish DateAugust 04, 2021

The International Society of Magnetic Resonance in Medicine awarded Natalie J. Serkova, the 2021 Senior Fellow Award for her work in animal imaging for oncology research. “I was humbled and ecstatic to receive this award…,” Serkova, director of the Animal Imaging Shared Resource at University of Colorado Cancer Center, said during an interview with Healio.

Full Story
Cure Today

Life With von Hippel-Lindau Disease

news outletCure Today
Publish DateAugust 03, 2021

At first, Camron King’s sixth-grade teacher thought he was nervous. King had just started at a new school when he told the teacher he couldn’t read aloud from his textbook. The problem, however, was more complicated than childhood stage fright.

Full Story